关于我们
新闻资讯
- 蓝海脑静脉,扬帆远航!一例脑静脉窦血栓患者成功运用Venus-TD脑静脉取栓装置清除颅内静脉窦血栓
- 大脑中动脉不同闭塞部位对接受血管内治疗的卒中患者临床结局的影响
- 【新资讯】首战告捷:全球首款脑静脉窦取栓装置完成注册临床试验首例入组
- 弘海微创:脑血管健康的保卫者
联系我们
联系人:王经理
手机:18801244288
电话:010-69803959
邮箱:marketing@hhtech-med.com
地址:北京市大兴区中关村科技园区大兴生物医药产业基地天荣街18号院1号楼1层
关于我们
北京弘海微创科技有限公司成立于 2017 年 11 月份,是一家以植/介入医疗器械研发、生产、销售于一体的创新型平台公司,聚焦于神经、外周、消化、泌尿、呼吸等植/介入领域的医疗器械研发,为医患提供完整的治疗方案。公司拥有全球独创的工艺技术,通过自主研发的设备,开发出具有卓越性能的植/介入医疗器械。
公司为国家高新技术企业、北京市专精特新中小企业、中关村高新技术企业、北京市科技型中小企业、北京市创新型中小企业,成立企业科协,北京市知识产权试点单位,国际发明专利 2 项(已授权 1 项,国际初审阶段 1 项),发明专利9 项,已取得三类医疗器械注册证书 3 张,二类注册证书 1 张。现有 2000 平方米的研发和生产基地,建有专业的研发和检测实验室。已获得国内外质量体系认证(无菌/植入质量体系、ISO13485、ISO9001),公司的生产加工平台专用于植/介入器械的加工制造,同时可为全球客户提供 ODM(原始设计制造商)服务。
Beijing Honghai Microcreate Technology Co., Ltd. was established in November 2017 as an innovative platform company integrating R&D, production, and sales of implant/interventional medical devices. It focuses on the R&D of medical devices in the fields of neural, peripheral, digestive, urinary, and respiratory implant/interventional areas to provide complete treatment solutions for patients and doctors. The company has a unique process technology globally and develops implant/interventional medical devices with outstanding performance through its own equipment.
The company is a high-tech enterprise in the country, a specialized, featured, and innovative enterprise in Beijing, a high-tech enterprise in Zhongguancun, a science and technology enterprise in Beijing, and a pilot unit for intellectual property work in Beijing. It has 2 international invention patents (one has been authorized, the other is under initial review), 9 invention patents, 3 third-class medical device registration certificates, and 1 second-class medical device registration certificate. It has a 2000-square-meter R&D and production base with professional R&D and testing laboratories. It has obtained domestic and foreign quality system certifications (sterile/implant quality system, ISO13485, ISO9001), and its production and processing platform is dedicated to the processing and manufacturing of implant/interventional devices, and can also provide ODM (original design manufacturer) services for global customers.